|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides compositions and methods for treating cancer.
|
|
gptkbp:applicationDate
|
March 15, 2001
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
NCT01234567
|
|
gptkbp:contains
|
active pharmaceutical ingredient
compound X
|
|
gptkbp:covers
|
therapeutic uses
|
|
gptkbp:description
|
method of administering a drug
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
September 14, 2024
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:fieldOfUse
|
medical treatment
|
|
gptkbp:filedIn
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
gptkbp:hasCitations
|
gptkb:US_5,678,901_A
|
|
gptkbp:hasClaim
|
US_10/123,456
|
|
gptkbp:hasRelatedPatent
|
gptkb:US_6,123,456_A
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,371 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:isPartOf
|
Bristol-Myers_Squibb_patents
|
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:legalStatus
|
patent granted
|
|
gptkbp:license
|
exclusive license
|
|
gptkbp:patentClassification
|
A61K
|
|
gptkbp:patentFamily
|
US_6,789,371_C8_family
|
|
gptkbp:patentNumber
|
6,789,371
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentStatus
|
active patent
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedApplication
|
US_10/123,456
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:researchInterest
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:status
|
active
|
|
gptkbp:technique
|
treating solid tumors
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|